The Disrupted Bodily Self of Patients
Launched by UNIVERSITY OF GENEVA, SWITZERLAND · Jun 30, 2021
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how some stroke patients experience a disconnect between their body and their sense of self. Specifically, it focuses on individuals who may feel as though certain parts of their body do not belong to them, a condition that can occur after a stroke affecting the right side of the brain. Researchers believe that using new methods, they can better detect these feelings of disownership, even in patients who appear to be doing fine during standard tests. The goal of the study is to test a new type of rehabilitation that uses multisensory stimulation, with the hope that it can help improve these feelings and support recovery.
To participate in this trial, potential candidates must have had a stroke that affected either side of the brain and have specific sensory deficits, such as challenges using their left hand. Participants should also be right-handed and able to communicate in French. The trial is not yet recruiting, but once it begins, participants can expect to engage in research sessions lasting at least 45 minutes, where they will undergo assessments and possibly receive new treatment aimed at improving their body awareness. It’s important to note that individuals with significant cognitive challenges or other neurological or psychiatric conditions may not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • First neurological event, affecting the right hemisphere or the left hemisphere (stroke);
- • Structural images of the brain lesion available (magnetic resonance or tomographic scans);
- • Full somato-sensory deficit affecting the left hand;
- • Good (or corrected) visual acuity;
- • Good proficiency in French;
- • Right-handed
- Exclusion Criteria:
- • Failure to meet the inclusion criteria ;
- • Presence of general cognitive deficits and/or suspicious of possible cognitive deficits;
- • Presence of difficulty in task's comprehension;
- • Impossibility to sustain a research session of at least 45minutes (e.g., attentional lability);
- • Precedent additional neurological disorder and/or current or precedent psychiatric disease.
About University Of Geneva, Switzerland
The University of Geneva, located in Switzerland, is a prestigious research institution renowned for its commitment to advancing scientific knowledge and improving public health. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials aimed at exploring innovative therapies and enhancing patient care. Its dedicated research teams, equipped with state-of-the-art facilities and a robust ethical framework, strive to translate scientific discoveries into practical applications, ultimately contributing to the global advancement of medical science and the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials